Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use

Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use

US Patent 5156977 · Granted Oct 20, 1992

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2025
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022
Branched 3-phenylpropionic acid derivatives and their use2022
Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2021
Substituted 5-fluoro-1H-pyrazolopyridines and their use2020
Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use2020
Heteroaryl-substituted imidazo[1,2-A]pyridines and their use2019
SGC stimulators in combination with additional treatment for the therapy of cyst2019
Branched 3-phenylpropionic acid derivatives and their use2019
Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof2019
Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibit2019